Investigation of Flare and Remission in Subjects With Atopic Dermatitis
Status:
Withdrawn
Trial end date:
2020-08-01
Target enrollment:
Participant gender:
Summary
The trial is an exploratory, single-centre, uncontrolled, open-label, interventional trial of
up to 19 weeks' duration to investigate flare and remission in subjects with
moderate-to-severe atopic dermatitis (AD) treated with cyclosporine A (CsA).